4.0 Article

A longitudinal twin study of fears from middle childhood to early adulthood - Evidence for a developmentally dynamic genome

期刊

ARCHIVES OF GENERAL PSYCHIATRY
卷 65, 期 4, 页码 421-429

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/archpsyc.65.4.421

关键词

-

向作者/读者索取更多资源

Context: While the nature of common fears changes over development, we do not know whether genetic effects on fear-proneness are developmentally stable or developmentally dynamic. Objective: To determine the temporal pattern of genetic and environmental effects on the level of intensity of common fears. Design: Prospective, 4-wave longitudinal twin study. Structural modeling was performed with Mx. Setting: General community. Participants: Two thousand four hundred ninety twins and their parents from the Swedish Twin Study of Child and Adolescent Development. Main Outcome Measure: The level of parent- and/or self-reported fears obtained at ages 8 to 9, 13 to 14, 16 to 17, and 19 to 20 years. Results: Thirteen questionnaire items formed 3 distinct fear factors: situational, animal, and blood/injury. For all 3 fears, the best-fit model revealed developmentally dynamic effects and, in particular, evidence for both genetic attenuation and innovation. That is, genetic factors influencing fear intensity at age 8 to 9 years decline substantially in importance over time. Furthermore, new sets of genetic risk factors impacting fear intensity come on line in early adolescence, late adolescence, and early adulthood. As the twins aged, the influence of the shared environment declined and unique environment increased. No sex effects were found for situational fears while for animal and blood/injury fears, genetic factors in males and females were correlated but not identical. Shared environmental factors were both more important and,more stable for animal fears than for situational or blood/injury fears. Conclusions: Genetic effects on fear are developmentally dynamic from middle childhood to young adulthood. As children age, familial-environmental influences on fears decline in importance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Familial co-aggregation of schizophrenia and eating disorders in Sweden and Denmark

Ruyue Zhang, Janne Tidselbak Larsen, Ralf Kuja-Halkola, Laura Thornton, Shuyang Yao, Henrik Larsson, Paul Lichtenstein, Liselotte Vogdrup Petersen, Cynthia M. Bulik, Sarah E. Bergen

Summary: The study found that eating disorders and schizophrenia co-occur and co-aggregate within the Swedish and Danish populations, indicating a familial contribution to the association between the two disorders. Individuals with anorexia nervosa or other eating disorders were more likely to have schizophrenia, and this risk varied among different relatives.

MOLECULAR PSYCHIATRY (2021)

Article Psychology, Developmental

A Co-Twin Control Study of the Association Between Bullying Victimization and Self-Harm and Suicide Attempt in Adolescence

Lauren M. O'Reilly, Erik Pettersson, Patrick D. Quinn, E. David Klonsky, Jessie R. Baldwin, Sebastian Lundstrom, Henrik Larsson, Paul Lichtenstein, Brian M. D'Onofrio

Summary: The study revealed an independent association between bullying victimization and self-harm/suicide attempt in adolescence, with small effect sizes, indicating the need for additional interventions beyond bullying prevention.

JOURNAL OF ADOLESCENT HEALTH (2021)

Article Psychology, Clinical

Associations between individual antipsychotics and the risk of arrests and convictions of violent and other crime: a nationwide within-individual study of 74 925 persons

Amir Sariaslan, Stefan Leucht, Johan Zetterqvist, Paul Lichtenstein, Seena Fazel

Summary: In individuals with psychiatric disorders, the use of specific antipsychotic medications such as clozapine, olanzapine, and risperidone is associated with lower risks of arrests and convictions for drug-related and violent crimes compared to other antipsychotics. Long-acting injectables, particularly risperidone, also show lower risks of these criminal outcomes.

PSYCHOLOGICAL MEDICINE (2022)

Article Substance Abuse

Association of selective serotonin re-uptake inhibitor (SSRI) treatment with acute substance misuse outcomes

Suvi Virtanen, Tyra Lagerberg, Lotfi Khemiri, Jaana Suvisaari, Henrik Larsson, Paul Lichtenstein, Zheng Chang, Antti Latvala

Summary: The cohort study in Sweden found that individuals with anxiety/depression had a higher risk of substance misuse before starting SSRI treatment, but the risk decreased after treatment initiation.

ADDICTION (2022)

Article Psychology, Developmental

Familial risk and heritability of intellectual disability: a population-based cohort study in Sweden

Paul Lichtenstein, Magnus Tideman, Patrick F. Sullivan, Eva Serlachius, Henrik Larsson, Ralf Kuja-Halkola, Agnieszka Butwicka

Summary: The study found that intellectual disability (ID) aggregates in families, with relatives of ID individuals at increased risk of ID in proportion to their degree of genetic relatedness. Genetic factors play a significant role in the development of ID, while male sex of relatives and maternal line of relationship with proband are associated with higher risk.

JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2022)

Article Neurosciences

Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study

Tyra Lagerberg, Seena Fazel, Arvid Sjoelander, Clara Hellner, Paul Lichtenstein, Zheng Chang

Summary: Using nationwide Swedish registers, researchers found that SSRI treatment did not increase the risk of suicidal behavior, but may actually reduce it. The risk of suicidal behavior decreased over time after SSRI treatment initiation, across different age groups and history of suicide attempts. Further research with different study designs and populations is warranted to confirm these findings.

NEUROPSYCHOPHARMACOLOGY (2022)

Letter Neurosciences

Reply to Ploderl and Hengartner: learning about the course of suicidal behavior but not about the effects of SSRIs

Tyra Lagerberg, Seena Fazel, Paul Lichtenstein, Zheng Chang

NEUROPSYCHOPHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Borderline personality disorder: associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors

Ashley E. Tate, Hanna Sahlin, Shengxin Liu, Yi Lu, Sebastian Lundstrom, Henrik Larsson, Paul Lichtenstein, Ralf Kuja-Halkola

Summary: This article presents one of the largest and most comprehensive studies on borderline personality disorder (BPD) to date. The study reveals that individuals diagnosed with BPD have higher risks of various psychiatric disorders, violent crime victimization, and self-harm. The study also finds that the risks are similar for both males and females with BPD. Additionally, having a sibling with BPD increases the risk for psychiatric disorders, trauma, and adverse behaviors.

MOLECULAR PSYCHIATRY (2022)

Article Biochemistry & Molecular Biology

The impact of educational attainment, intelligence and intellectual disability on schizophrenia: a Swedish population-based register and genetic study

Jie Song, Shuyang Yao, Kaarina Kowalec, Yi Lu, Amir Sariaslan, Jin P. Szatkiewicz, Henrik Larsson, Paul Lichtenstein, Christina M. Hultman, Patrick F. Sullivan

Summary: Schizophrenia is a highly heterogeneous disorder with no well-characterized subtypes for treatment response or longitudinal course. Cognitive impairment, a core clinical feature of schizophrenia, is strongly associated with poorer outcomes. This study investigates the complex genetic overlap between schizophrenia and cognitive traits using comprehensive epidemiological and genomic evidence. The findings highlight the robust relationship between cognitive traits and schizophrenia, emphasizing the importance of cognition in understanding the heterogeneity of the disorder.

MOLECULAR PSYCHIATRY (2022)

Article Psychiatry

The role of ADHD genetic risk in mid-to-late life somatic health conditions

Miguel Garcia-Argibay, Ebba du Rietz, Yi Lu, Joanna Martin, Elis Haan, Kelli Letho, Sarah E. Bergen, Paul Lichtenstein, Henrik Larsson, Isabell Brikell

Summary: Growing evidence suggests that ADHD is associated with poor somatic health in adulthood, but the mechanisms underlying these associations are poorly understood. This study found that ADHD polygenic risk scores (PRS) are associated with multiple somatic health problems in mid-to-late life, particularly in the cardiometabolic domain. These associations were observed in the general population and appear to be partially mediated by life-course risk factors.

TRANSLATIONAL PSYCHIATRY (2022)

Correction Psychiatry

The role of ADHD genetic risk in mid-to-late life somatic health conditions (vol 12, 166, 2022)

Miguel Garcia-Argibay, Ebba du Rietz, Yi Lu, Joanna Martin, Elis Haan, Kelli Lehto, Sarah E. Bergen, Paul Lichtenstein, Henrik Larsson, Isabell Brikell

TRANSLATIONAL PSYCHIATRY (2022)

Article Psychiatry

Cardiovascular risk factors in attention-deficit/hyperactivity disorder: A family design study of Swedish conscripts

Miguel Garcia-Argibay, Ebba Du Rietz, Catharina A. Hartman, Paul Lichtenstein, Zheng Chang, Cristiano Fava, Samuele Cortese, Henrik Larsson

Summary: This study found that there is an association between cardiovascular risk factors and ADHD, and this association is not influenced by medication treatment for ADHD, but is partly due to shared familial risk factors.

INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2022)

Article Biochemistry & Molecular Biology

Predicting childhood and adolescent attention-deficit/hyperactivity disorder onset: a nationwide deep learning approach

Miguel Garcia-Argibay, Yanli Zhang-James, Samuele Cortese, Paul Lichtenstein, Henrik Larsson, Stephen V. V. Faraone

Summary: This study examined the use of different machine learning techniques to assess the feasibility of using registry data for diagnosing ADHD in children and adolescents in Sweden. The findings showed that a DNN model achieved good predictive ability for ADHD and identified several important features for classification. If validated and proven to be cost-effective in external samples, this model could potentially serve as a useful tool in clinical practice to aid in ADHD screening and decision-making.

MOLECULAR PSYCHIATRY (2023)

Article Psychiatry

A genetically informed prediction model for suicidal and aggressive behaviour in teens

Ashley E. Tate, Wonuola A. Akingbuwa, Robert Karlsson, Jouke-Jan Hottenga, Rene Pool, Magnus Boman, Henrik Larsson, Sebastian Lundstrom, Paul Lichtenstein, Christel M. Middeldorp, Meike Bartels, Ralf Kuja-Halkola

Summary: This study aimed to create a model that predicted if individuals will exhibit suicidal behaviour, aggressive behaviour, both, or neither in late adolescence. The model was validated using twin samples from Sweden and the Netherlands, and showed generalizability across Northern Europe. However, the model's prediction performance for suicidal behavior in the Netherlands sample was not better than chance.

TRANSLATIONAL PSYCHIATRY (2022)

Article Psychiatry

Association between cumulative psychosocial adversity in the family and ADHD and autism: a family-based cohort study

Aleksandra Kanina, Henrik Larsson, Arvid Sjolander, Agnieszka Butwicka, Mark J. J. Taylor, Miriam I. I. Martini, Paul Lichtenstein, Frida E. E. Lundberg, Brian M. D. Onofrio, Mina A. A. Rosenqvist

Summary: Cumulative exposure to psychosocial adversity at an early age has been found to increase the risk of ADHD and autism, but it is unclear if this association is causal or due to familial confounding. This study used a population-based cohort in Sweden to examine the relationship between cumulative psychosocial adversity and neurodevelopmental conditions. The results showed a dose-response relationship between psychosocial adversity and ADHD, but no clear dose-response relationship for autism. The findings also highlighted the importance of accounting for familial confounding in studies of psychosocial adversity and neurodevelopmental conditions.

TRANSLATIONAL PSYCHIATRY (2023)

暂无数据